-
M. Berdugo-Polak
INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
Pierre et Marie Curie University, Paris 6, Paris, France
-
I. V. Larsen
Department of Ophthalmology and Visual Sciences,
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
-
C. Abadie
ribOvax Biotechnologies, Petit-Lancy, Switzerland
-
L. Kowalczuk
INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
Pierre et Marie Curie University, Paris 6, Paris, France
-
E. Touchard
INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
Pierre et Marie Curie University, Paris 6, Paris, France
-
J. D. Nelson
Calmune Corporation, San Diego, California
-
P. P. Elena
Iris Pharma, La Gaude, France
-
C. R. Brandt
Department of Ophthalmology and Visual Sciences,
Department of Medical Microbiology and Immunology,
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
-
F. Behar-Cohen
INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
Pierre et Marie Curie University, Paris 6, Paris, France
Hotel-Dieu University Hospital, Paris, France
-
J.-M. Combette
ribOvax Biotechnologies, Petit-Lancy, Switzerland